A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults
Study sponsor: Arcturus Therapeutics, Inc.
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2022-03-01Actual
Enrollment · participants581Actual
Source updated2025-05-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.